RECRUITING

Developing a Culturally Relevant Supportive Care Program for Black Patients Dealing With Advanced Cancer

Conditions

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

To determine the feasibility of implementing a culturally adapted mind-body intervention (Meditation-Based Support-Adapted; MBS-A) as a supportive care strategy in Black patients diagnosed with a stage III-IV solid malignancy. To target the specific needs of Black advanced cancer patients, we will first conduct formative research that includes quantitative surveys and in-depth interviews of patients and their primary caregivers. The purpose of this formative research is to determine the intervention format for the MBS-A program (family- vs group-based) that promises the greatest likelihood of success and to solicit input on the original MBS intervention regarding content that needs adaptation. Once the intervention format is determined and content adapted, we will conduct a pilot randomized controlled trial (RCT) to examine the feasibility of the MBS-A intervention vs. a dose-matched attention control (AC) group receiving a psychoeducation intervention.

Official Title

Developing a Culturally Relevant Supportive Care Program for Black Patients Dealing With Advanced Cancer

Quick Facts

Study Start:2023-04-13
Study Completion:2029-03-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05763797

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Self-identifies as Black/African American
  2. * Is ≥18 years old
  3. * Was diagnosed with a stage III-IV solid tumor
  4. * Is able to provide informed consent
  5. * Self-identifies as Black/African American
  6. * Is ≥18 years old
  7. * Was diagnosed with a stage III-IV solid tumor
  8. * Is on active treatment (any line)
  9. * Has an ECOG performance status of ≤2
  10. * Has access to the internet
  11. * Is able to provide informed consent
  12. * Is ≥18 years old
  13. * Has access to the internet
  14. * Is able to provide informed consent
  1. * Is pregnant
  2. * Has cognitive deficits that would impede the completion of self-report instruments as deemed by the clinical team
  3. * Participated in in the Aim 1 of this study

Contacts and Locations

Study Contact

Dalnim Cho, PhD
CONTACT
(713) 745-8476
dcho1@mdanderson.org

Principal Investigator

Dalnim Cho, PhD
PRINCIPAL_INVESTIGATOR
M.D. Anderson Cancer Center

Study Locations (Sites)

M D Anderson Cancer Center
Houston, Texas, 77030
United States

Collaborators and Investigators

Sponsor: M.D. Anderson Cancer Center

  • Dalnim Cho, PhD, PRINCIPAL_INVESTIGATOR, M.D. Anderson Cancer Center

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2023-04-13
Study Completion Date2029-03-31

Study Record Updates

Study Start Date2023-04-13
Study Completion Date2029-03-31

Terms related to this study

Additional Relevant MeSH Terms

  • Cancer